Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes

Free Radical Research

Volumn 41, Issue 6, 2007, Pages 688-698

  Lemarechal, Herve ^a   Anract, Philippe ^a   Beaudeux, Jean Louis ^b   Bonnefont Rousselot, Dominique ^b   Ekindjian, Ovanhesse G ^a   Borderie, Didier ^a,b  

^a Assistance Publique Hôpitaux de Paris ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Oxidative stress; Rheumatoid arthritis; Synoviocytes; Thioredoxin reductase

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; GLUCOCORTICOID; HYDROGEN PEROXIDE; HYDROXYCHLOROQUINE; MESSENGER RNA; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SELENOCYSTEINE; SUPEROXIDE; THIOREDOXIN REDUCTASE; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LOW DRUG DOSE; MALE; OSTEOARTHRITIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; HYDROGEN PEROXIDE; HYPOXANTHINE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES; SYNOVIAL MEMBRANE; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); XANTHINE OXIDASE;

EID: 34249820793     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701294468     Document Type: Article

References (46)

1. Pap, T., Muller-Ladner, U., Gay, RE and Gay, S. (2000) Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther, 2, pp. 61-67.
2. Firestein, GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum, 39, pp. 1781-1790.
3. Tak, PP, Zwaifler, NJ, Green, DR and Firestein, GS (2000) Rheumatoid arthritis and p53: How oxidative stress might alter the course of inflammatory diseases. Immunol Today, 21, pp. 78-82.
4. Mapp, PI, Grootved, MC and Blake, DR (1995) Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull, 51, pp. 419-436.
5. Hitchon, CA and El-Gabalawy, H. (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther, 6, pp. 265-278.
6. Bowie, A. and O'Neill, LA (2000) Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol, 59, pp. 13-23.
7. Cemerski, S., van Meerwijk, JP and Romagnoli, P. (2003) Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol, 33, pp. 2178-2185.
8. Heliovaara, M., Knekt, P., Aho, K., Aaran, RK, Alfthan, G. and Aromaa, A. (1994) Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis, 53, pp. 51-53.
9. Hagfors, L., Leanderson, P., Skoldstam, L., Andersson, J. and Johansson, G. (2000) Antioxodant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J, 3, pp. 2-5.
10. Salvemini, D., Mazzon, E., Dugo, L., Serraino, I., De Sarro, A., Caputi, AP and Cuzzocrea, S. (2001) Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum, 44, pp. 2909-2921.
11. Maurice, MM, Nakamura, H., van der Voort, EAM, van Vliet, AI, Staal, FJT, Tak, PP, Breedveld, FC and Verweij, CL (1997) Evidence for a role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol, 158, pp. 1458-1465.
12. Maurice, MM, Nakamura, H., Gringhuis, S., Okamoto, T., Yoshida, S., Kullmann, F., Lechner, S., van der Voort, EAM, Leow, A., Versendaaal, J., Muller-Ladner, U., Yodoi, J., Tak, PP, Breedveld, FC and Verweij, CL (1999) Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum, 42, pp. 2430-2439.
13. Yoshida, S., Katoh, T., Tessuka, T., Uno, K., Matsui, N. and Okamoto, T. (1999) Involvement of thioredoxin in rheumatoid arthritis: Its costimulatory roles in the TNF-alpha induced production of IL-6 and IL-8 cultured synovial fibroblasts. J Immunol, 163, pp. 351-358.
14. Jikimoto, T., Nishiikubo, Y., Koshiba, M., Kanagawa, S., Morinobu, S., Morinobu, A., Saura, R., Mizuno, K., Kondo, S., Toyokuni, S., Nakamura, H., Yodoi, J. and Kumagai, S. (2001) Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol, 38, pp. 765-772.
15. Lemarechal, H., Allanore, Y., Chenevier-Gobeaux, C., Ekindjian, OG, Kahan, A. and Borderie, D. (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta, 367, pp. 156-161.
16. Holmgren, A. (1985) Thioredoxin. Annu Rev Biochem, 54, pp. 237-271.
17. Tanaka, T., Nakamura, H., Nishiyama, A., Hosoi, F., Masuta, IH, Wada, H. and Yodoi, J. (2000) Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic Res, 33, pp. 851-855.
18. Powis, G. and Montfort, WR (2001) Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol, 41, pp. 261-295.
19. Sun, QA, Zappacosta, F., Jeang, KT, Lee, BJ, Hatfield, DL and Gladyshev, VN (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductase. J Biol Chem, 274, pp. 24522-24530.
20. Berlett, BS and Stadtman, ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem, 272, pp. 20313-20316.
21. Levine, RL (2002) Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med, 32, pp. 790-796.
22. Arnett, FC, Edworthy, SM, Bloch, DA, McShane, DJ, Fries, JF, Cooper, NS, Healey, LA, Kaplan, SR, Liang, MH and Luthra, HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 31, pp. 315-324.
23. Hernvann, A., Aussel, C., Cynober, L., Moatti, N. and Ekindjian, OG (1992) IL-1β, a strong mediator for glucose uptake by rheumatoid and non rheumatoid cultured human synoviocytes. FEBS Lett, 303, pp. 77-80.
24. Arner, ES, Zhong, L. and Holmgren, A. (1999) Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol, 300, pp. 226-239.
25. Gasdaska, PY, Gasdaska, JR, Cochran, S. and Powis, G. (1995) Cloning and sequencing of a human thioredoxin reductase. FEBS Lett, 373, pp. 5-9.
26. Katoh, M. (2002) Expression and regulation of WNT1 in human cancer: Up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int J Oncol, 22, pp. 209-212.
27. Reznick, AZ and Packer, L. (1994) Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol, 233, pp. 357-363.
28. Kim, JR, Yoon, HW, Kwon, KS, Lee, SR and Rhee, SG (2000) Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem, 283, pp. 214-221.
29. Beauchamp, C. and Fridovich, I. (1971) Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem, 44, pp. 276-287.
30. Aebi, H. (1984) Catalase in vitro. Methods Enzymol, 105, pp. 121-126.
31. Baker, MA, Cerniglia, GJ and Zaman, A. (1990) Microliter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem, 190, pp. 360-365.
32. Yamada, KI, Nakamura, T. and Utsumi, H. (2006) Enhanced intraarticular free radical reactions in adjuvant arthritis rats. Free Radic Res, 40, pp. 455-460.
33. Bjornstedt, M., Hamberq, M., Kumar, S., Xue, J. and Holmgren, A. (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH ans selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem, 270, pp. 11761-11764.
34. May, JM, Mendiratta, S., Hill, KE and Burk, RF (1997) Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem, 272, pp. 22607-22610.
35. Das, KC, Lewis-Molock, Y. and White, CW (1997) Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol, 17, pp. 713-726.
36. Kim, JR, Lee, SM, Cho, SH, Kim, JH, Kim, BH, Kwon, J., Choi, CY, Kim, YD and Lee, SR (2004) Oxidation of thioredoxin reductase in Hela cells stimulated with tumor necrosis factor-alpha. FEBS Lett, 567, pp. 189-196.
37. Park, YS, Fujiwara, N., Koh, YH, Miyamoto, Y., Suzuki, K., Honke, K. and Taniquchi, N. (2002) Induction of thioredoxin reductase gene expression by peroxynitrite in human umbilical vein endothelial cells. Biol Chem, 383, pp. 683-691.
38. Lee, SR, Bar-Noy, S., Kwon, J., Levine, RL, Stadtman, TC and Rhee, SG (2000) Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA, 97, pp. 2521-2526.
39. Fujiwara, N., Fuji, T., Fuji, F. and Taniquchi, N. (2001) Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase. J Biochem (Tokyo), 129, pp. 803-812.
40. Gromer, S., Wissing, J., Behne, D., Ashman, K., Schirmer, RH, Flohe, L. and Becker, K. (1998) A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J, 332, pp. 591-592.
41. Gorlatov, SN and Stadtman, TC (1998) Human thioredoxin reductase from Hela cells: Selective alkylation of the selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc Natl Acad Sci USA, 95, pp. 8520-8525.
42. Fang, J. and Holmgren, A. (2006) Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc, 128, pp. 1879-1885.
43. Jaswal, S., Metha, HC, Sood, AK and Kaur, J. (2003) Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta, 338, pp. 123-129.
44. Anestal, K. and Arner, ES (2003) Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem, 278, pp. 15966-15972.
45. Li, PF, Dietz, R. and von Harsdorf, R. (1997) Reactive oxygen species induce apoptosis of vascular smooth muscle cells. FEBS Lett, 404, pp. 249-252.
46. Tsuji, G., Koshiba, M., Nakamura, H., Kosada, H., Hatachi, S., Kurimoto, C., Kurosada, M., Hayashi, Y., Yodoi, J. and Kumagai, S. (2006) Thioredoxin protects against joint destruction in a murine arthritis model. Free Radic Biol Med, 40, pp. 1721-1731.